TRPV1 and Alzheimer disease: Transient receptor potential vanilloid subfamily V member 1 (TRPV1) antagonist. Activated TRPV1 on keratinocytes, mast cells, and cutaneous sensory nerves induces the release of IL-31, which mediates itch, and molecules that suppress the Th2 pathway in AD.